Prescription Weight Loss Drugs
 
   
 
 
PRESS RELEASES Weight Loss Drugs Prescription Weight Loss Drug
 
 
Home > Press Releases > Prescription Weight Loss Drugs  
 
 

Prescription Weight Loss Drugs

Prescription weight loss drug may go OTC, prompting concern about broad use of diet pills.

BOSTON —In January 2006, a federal advisory panel recommended that the FDA make the weight-loss medication orlistat (Xenical) available without a prescription. Although the FDA usually takes the panel’s advice, orlistat’s approval is uncertain. Many question the drug’s effectiveness in the broader population ; others worry about its side effects, reports the April issue of Harvard Women’s Health Watch.

A new weight-loss solution would be welcome; two-thirds of adults in the United States are overweight or obese and at risk for major health problems and early death. But the reasons for weight problems are complex. No pill can melt away fat or keep the pounds off. Yet for people whose health is at risk, drug therapy may increase the odds of success.

Even though weight-loss drugs have a role to play in medical treatment, their long-term safety is unknown, says Harvard Women’s Health Watch. And like all medications, they can pose problems. Orlistat, which inhibits the body’s ability to take in fats, can also interfere with the absorption of certain vitamins.

The National Institutes of Health advises that diet drugs be taken only by severely overweight people who need them for health reasons, and only in combination with lifestyle modifications. For example, one study found that people taking the weight-loss drug Meridia (sibutramine) who also received counseling on diet and exercise lost twice as much weight as those who received either Meridia or counseling alone.

The bottom line: The Harvard Women’s Health Watch says that weight-loss drugs can help, but they’re not the ultimate solution. The key to long-term weight loss is effort on many fronts.

Also in this issue:

  • Hormone therapy and your heart
  • Stem cell therapy for lupus
  • Inhaled insulin
  • Angle-closure glaucoma
  • Soy is losing its luster
  • A doctor answers: Should I be vaccinated against cervical cancer?

Harvard Women’s Health Watch is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at www.health.harvard.edu/women or by calling 1-877-649-9457 (toll free).

RSS | XML FEED

The Harvard Women's Health Watch is available from Harvard Health Publications, the publishing division of the Harvard Medical School. You can subscribe to The Harvard Women's Health Watch for $24 per year at www.health.harvard.edu or by calling 1-877-649-9457 toll-free.

About Harvard Health Publications
Harvard Health Publications publishes five monthly newsletters—Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, Harvard Mental Health Letter, and Harvard Heart Letter—as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals. For more information about Harvard Medical School publications, please visit our Web site, www.health.harvard.edu.

Source: Harvard Health Publications
Contact: hhpmedia@hms.harvard.edu
Web site: http://www.health.harvard.edu

 

Bookstore
Newsletters
Harvard Health Letter
Harvard Women’s Health Watch
Harvard Men’s Health Watch
Harvard Heart Letter
Harvard Mental Health Letter
Perspectives on Prostate Disease
Premium Access
Special Reports
Exercise
Vitamins
Skin Care
Stress Management
Foot Care
See All Titles
Books
Your Developing Baby
The Fertility Diet
Eat, Drink, and Be Healthy
Beating Diabetes
The Harvard Medical School Family Health Guide
See All Titles
Browse
Common Medical Conditions
Wellness & Prevention
Emotional Well Being & Mental Health
Women’s Health
Men’s Health
Heart & Circulatory Health
Tools
Guide to Diagnostic Tests